Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 50%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is a leading virtual healthcare provider with a specialized care platform that supports individuals with chronic conditions, including cardiometabolic issues and behavioral health needs. Recent partnerships with Optum and Eli Lilly, along with strong member engagement and retention rates, provide a strong foundation for continued growth. With the potential for expanding margins and a growing customer base, Omada Health presents a compelling investment opportunity for investors looking for exposure to the growing digital health market.

Bears say

Omada Health is strategically partnering with pharmaceutical giant Eli Lilly, allowing access to its GLP-1 Care Track and prescribing capabilities to Lilly's Employer Connect program focused on cardiometabolic conditions. This partnership could potentially bring in new revenues for Omada, but the competitive telehealth market and recent healthcare regulations may pose challenges for the company's growth and profitability. Additionally, Omada's stock has been volatile in the past year, with fluctuations in its financials and market sentiment further indicating a negative outlook for the stock.

OMDA has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 50% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 12 analysts, OMDA has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.